Cleary Gottlieb is representing Actavis, which announced the pricing of public offerings of $3.8 billion of Ordinary Shares and $4.6 billion of Mandatory Convertible Preferred Shares in connection with the pending acquisition of Allergan.
This transaction is the largest healthcare equity offering ever and the largest non-financial mandatory convertible preferred shares offering ever.